Clinical Trial

Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2024 (before its estimated November 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
The object of this study is to observe the safety of umbilical cord mesenchymal stem cell therapy for acute respiratory distress syndrome, consisting with two phases.
Trial Details
NCT Number NCT06505941
Lead Sponsor Southeast University, China
Collaborators: Zhongda Hospital, Yinguan Biologics, Shenzheng
Conditions Acute Respiratory Distress Syndrome
Enrollment 60 participants
Start Date 2024-07-20
Primary Completion 2025-11-20 (estimated)
Study Completion 2027-02-20 (estimated)
Updated on ClinicalTrials.gov 2024-07-17